Back to mobile site

Matinas BioPharma (MTNB) Commences Public Offering of Common Stock

March 14, 2019 5:02 PM EDT Send to a Friend
Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login